Aflac Incorporated (NYSE:AFL) Shares Sold by Northcape Wealth Management LLC

Northcape Wealth Management LLC decreased its stake in Aflac Incorporated (NYSE:AFL) by 12.6% in the 3rd quarter, Holdings Channel reports. The firm owned 4,004 shares of the financial services provider’s stock after selling 577 shares during the quarter. Northcape Wealth Management LLC’s holdings in Aflac were worth $448,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Strategic Financial Concepts LLC grew its holdings in Aflac by 7,001.0% in the second quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider’s stock valued at $596,000 after purchasing an additional 658,303 shares during the last quarter. International Assets Investment Management LLC grew its stake in Aflac by 10,878.5% in the 3rd quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider’s stock valued at $62,597,000 after acquiring an additional 554,803 shares during the last quarter. Truist Financial Corp increased its holdings in Aflac by 26.6% during the 2nd quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock valued at $172,338,000 after acquiring an additional 405,847 shares in the last quarter. Swedbank AB acquired a new position in Aflac during the first quarter worth about $27,588,000. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of Aflac by 6.3% in the second quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock valued at $429,319,000 after purchasing an additional 285,576 shares in the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

Shares of NYSE:AFL opened at $111.32 on Friday. The business has a 50-day moving average of $110.41 and a two-hundred day moving average of $99.48. The firm has a market capitalization of $61.84 billion, a PE ratio of 16.77, a P/E/G ratio of 2.13 and a beta of 0.96. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.08. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, beating the consensus estimate of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. During the same quarter last year, the firm posted $1.84 earnings per share. Aflac’s revenue for the quarter was down 40.4% compared to the same quarter last year. As a group, research analysts forecast that Aflac Incorporated will post 7.22 earnings per share for the current year.

Aflac Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac’s dividend payout ratio is presently 30.12%.

Analyst Ratings Changes

Several equities analysts have weighed in on AFL shares. Citigroup raised their price target on Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 23rd. Truist Financial boosted their target price on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, November 1st. TD Cowen started coverage on shares of Aflac in a research note on Wednesday, October 9th. They set a “hold” rating and a $102.00 price target on the stock. Piper Sandler boosted their price objective on shares of Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Morgan Stanley raised their target price on shares of Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Monday, August 19th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Aflac presently has a consensus rating of “Hold” and an average price target of $97.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.